US2017007529A1PendingUtilityA1
Oral care compositions
Est. expiryDec 20, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61K 8/49A61Q 11/00A61K 8/81A61K 8/463A61K 8/21A61K 8/368A61K 8/25A61K 8/86A61K 8/362A61K 8/24A61K 2800/54C07C 57/15A61P 1/02A61K 8/19
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are compositions comprising a fluoride ion source, a poly(propylene oxide)/poly(ethylene oxide) copolymer, and optionally a sparingly soluble acid; and methods of using and of making the same.
Claims
exact text as granted — not AI-modified1 . An oral care composition comprising:
a fluoride ion source; and a poly(propylene oxide)/poly(ethylene oxide) copolymer in an amount effective to provide greater than 90% recovery of soluble fluoride ions after 3 months at 40° C., wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer is present in an amount of from about 2.5% to about 5%, by weight, of the composition.
2 . The composition of claim 1 , further comprising a sparingly soluble acid in an amount effective to enhance delivery of fluoride to the enamel.
3 . The composition of claim 1 , wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer has a molecular weight of from about 8,000 to about 18,000 g/mol, and an ethylene oxide content of from about 30 to about 90%, by weight of the copolymer.
4 . The composition of claim 1 , wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer has a molecular weight of from about 12,000 to about 15,000 g/mol, and an ethylene oxide content of from about 70 to about 80%, by weight of the copolymer.
5 . The composition of claim 1 , wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer is selected from: Poloxamer 237; Poloxamer 217; Poloxamer 184; Poloxamer 185; Poloxamer 188; Poloxamer 338; Poloxamer 407; and a combination of two or more thereof.
6 . The composition of claim 3 , wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer is selected from Poloxamer 237; Poloxamer 188; Poloxamer 338; Poloxamer 407; and a combination of two or more thereof.
7 . The composition of claim 1 , wherein the poly(propylene oxide)/poly(ethylene oxide) copolymer is selected from: Poloxamer 338; Poloxamer 407; and a combination of two or more thereof.
8 . (canceled)
9 . (canceled)
10 . The composition of claim 1 , wherein the sparingly soluble acid is present in an amount of from about 0.01 to about 0.25%, of the total composition weight.
11 . The composition of claim 1 , wherein the fluoride ion source is selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, titanium fluoride, hexafluorosulfate, silver diamine fluoride, indium 10 fluoride, zinc fluoride, and a combination of two or more thereof.
12 . The composition of claim 1 , wherein the fluoride ion source is present in an amount of about 0.01 wt. % to about 2 wt. % of the total composition weight.
13 . The composition of claim 1 , wherein the pH is about 6.5 to about 7.5 in undiluted form, and wherein the pH of the composition is lowered from about 0.6 to about 2 pH units, during use.
14 . The composition of claim 1 any foregoing claim 1 , further comprising a calcium ion source.
15 . The composition of claim 14 , wherein the calcium ion source is tricalcium phosphate hydroxyapatite, dicalcium phosphate dihydrate, calcium pyrophosphate, amorphous calcium phosphate, or mixtures thereof present in an amount of about 0.01 to about 1% of the total composition weight.
16 . The composition of claim 1 , in a form selected from: a mouthrinse, a toothpaste, a tooth gel, a tooth powder, a non-abrasive gel, an oral care mousse, a foam, mouth spray, a lozenge, a tablet, a dental implement, and a pet care product.
17 . A method of enhancing delivery of fluoride to tooth enamel comprising applying an effective amount of the composition according to any foregoing claim to the oral cavity of a subject in need thereof.
18 . A method of enhancing protection of teeth against caries and cavities and increasing resistance to acid demineralization comprising administering to the oral cavity, of a subject in need thereof, a composition according to claim 1 .
19 . Use of a composition according to claim 1 , for the manufacture of a medicament for enhancing protection of teeth against caries and cavities and increasing resistance to acid demineralization.
20 . Use of a composition according to claim 1 , for enhancing protection of teeth against caries and cavities and increasing resistance to acid demineralization.
21 . A composition according to claim 1 for use in enhancing delivery of fluoride to tooth enamel.
22 . A composition according to claim 1 for use in enhancing protection of teeth against caries and cavities and increasing resistance to acid demineralization.Join the waitlist — get patent alerts
Track US2017007529A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.